Our previous work showed that expressions of some mesenchymal genes do not require ZEB1 activation and that the high expression of a group of EMT genes positively controlled by ZEB1, but not TGF-β, is correlated with better prognosis of breast cancer patients [25]. This evidence concerns the gene ZEB1 and breast carcinoma.